Say again please
Yesterday was an unusual day with Livongo actually going up while the markets were going down. Is this the long anticipated dead cat bounce or is this the start of climb back up? Only time will tell but one thing became very apparent yesterday the company’s CEO Glen Tullman is clueless to the situation and seems to care less that he and his team are destroying shareholder value. As we noted...
Radio Silence
According to the S-1 Livongo filed before going public; “Our mission is to empower people with chronic conditions to live better and healthier lives.” The mission statement says nothing about how in the pursuit of this empowerment the company plans to take care of their stakeholders, many of whom that invested millions to advance this empowerment kick. Yes, we know that West Coast Mafia and their ilk just love this empowerment...
End Game?
It looks as if our friends at Bigfoot have suffered another blow with the recent departure of their Vice President of Clinical and Medical Affairs who has moved onto greener pastures accepting a Medical Affairs and Research position at Apple. As we noted after the company went through a major staff reduction the clock has begun ticking and without a fresh infusion of desperately needed capital future operations are in...
Is it real?
As we begin the new week and for our fellow tribe members a New Year one question that remains unanswered is how long will the Livongo limbo last and just how low can this stock go. As we begin trading this morning the stock sits at $17.05 down some 55% since its IPO back in late July. In an astonishing move downward the stock has plummeted over 22% in the...
How will it end?
For a week with no major conferences this sure has been an interesting one. As we head towards the weekend and for our fellow tribe members a New Year the question is how will it end. To say that Livongo has a had a bad week is an understatement. The stock opened on Monday at $23.85 closing yesterday at $17.89, heaven knows where it will trade today. Will at long...
We found one
In our continuing quest to provide accurate reliable information we think we have found an example of diabetes company that went public only to see its stock price crash and burn. Now we will admit we cannot find ANY company that has crashed and burned as quickly as Livongo has. Remember the company has only been publicly traded since the last week of July and we aren’t yet into October....
The music ends
Having been around awhile we tend to get just a little cranky when we see companies do stupid things that have nothing to do with their core competencies, that of course assumes they have a core competency. One of the dumber things is taking a simple, easy to remember name and changing it to something they think is way cool wand whiz bang that no understands or can remember. The...
Welcome to the Ice Age
Momma Kliff used to say even when your right and everyone else was wrong there is no reason to gloat. Well this is one time when we will divert from Mom’s advice and gloat just a little as the digital diabetes space has gone from being hotter than Georgia asphalt to colder than Chicago during winter. Shares of Livongo continue to sell off with everyone looking for a reason why...
The Livongo Limbo How Low Can it Go
While we can’t say we are shocked by the continued skid in Livongo’s share price since its IPO, it is somewhat surprising how quickly investors have bailed. As we noted in many past posts on Livongo and the love analysts had for the company, this had all the signs of a classic pump and dump. We just expected more pumping before the dumping began. Consider the following; The company went public...
Sailing into treacherous waters
As expected the FDA approved Rybselsus Novo Nordisk once daily orally delivered GLP-1 and as expected the drug carries a list price on par with Ozempic, which of course is meaningless as the company will not release the level of discounts they will offer or how much they are rebating. The company also noted they have no plans to add additional reps meaning that the same reps who sell...